22 May 2013
Keywords: s-p, antifungal, noxafil, gets, fda, ok, drugmaker
Article | 25 September 2006
US drugmaker Schering-Plough says that the Food and Drug Administration has approved its oral antifungal Noxafil (posaconazole) for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 September 2006
21 May 2013
© 2013 thepharmaletter.com